http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018143140-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e5c121269689cbab9b3a4548b15caf3
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N45-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01G7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N47-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N45-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01G7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N53-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N47-28
filingDate 2018-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b1100dd62d79f4725fe69d155b8498c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96851b9e5dfee5d7a47312a5ba6f981c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01c8d188692c6b80a3e204a74ab6c607
publicationDate 2018-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2018143140-A1
titleOfInvention Fusicoccin compound
abstract Through the fusicoccin compound according to the present invention represented by general formula (1A), PPI stabilization effect can be enhanced. [In the formula, Y represents a carbonyl group, a sulfonyl group, or a substituted or unsubstituted alkylene group; R 1 and R 2 are the same or different and represent a hydrogen atom or a hydroxyl group; R 3 represents a hydrogen atom, a substituted or unsubstituted aminoalkyl group, or a group represented by general formula (2) (In general formula (2), R 5 represents a hydrogen atom or a substituted or unsubstituted alkyl group; R 6 represents a hydrogen atom; R 5 and R 6 may be bonded and form a substituted or unsubstituted alkylene group; and the symbol * represents a bond.); R 4a represents a substituted or unsubstituted alkyl group, a substituted or unsubstituted (hetero)cycloalkyl group, a substituted or unsubstituted alkoxy group, a substituted or unsubstituted (hetero)aryl group, or a substituted or unsubstituted amino group; and the case of R 4a representing an epoxy group is excluded when Y is a carbonyl group, R 1 is a hydroxyl group, R 2 is a hydrogen atom, and R 3 is a group represented by general formula (2).]
priorityDate 2017-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013031975-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010090234-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008010324-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468150860
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46936214
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226522263

Total number of triples: 35.